The Journal of Organic Chemistry
Featured Article
2.0, H-6), 3.71−3.65 (m, 2H, H-5, H-6), 3.61 (app t, 1H, J = 9.1 Hz,
H-3′), 3.55−3.49 (m, 3H, H-2′, H-4, H-4′), 3.33 (s, 3H, OCH3), 3.17
(d, 1H, J = 3.5 Hz, 4-OH), 2.50 (d, 1H, J = 3.8 Hz, 3-OH), 1.25 (s,
9H, (CH3)3CCO). 13C NMR (100 MHz, CDCl3): δ (ppm) 178.5,
138.6, 138.5, 138.1, 138.0, 128.6, 128.5, 128.5, 128.5, 128.2, 128.1,
128.0, 127.95, 127.89, 127.85, 127.81, 127.7, 103.9, 97.2, 84.8, 82.1,
77.9, 75.8, 75.1, 74.9, 74.9, 73.6, 73.3, 71.9, 71.7, 70.1, 69.3, 69.0, 55.5,
39.0, 27.2. HRMS (ESI, m/z): calcd for [C46H60NO12] (M + NH4)+
818.4110, found 818.4112.
(s), 1043 (s), 734 (s), 696 (s). 1H NMR (400 MHz, CDCl3): δ (ppm)
7.38−7.26 (m, 18H, ArH), 7.17−7.15 (m, 2H, ArH), 5.35 (app t, 1H, J
= 10.2, 9.2 Hz, H-3), 5.00 (d, 1H, J = 10.9 Hz, PhCH), 4.94 (d, 1H, J
= 11.0 Hz, PhCH), 4.94 (d, 1H, J = 3.7 Hz, H-1), 4.83−4.79 (m, 3H,
H-2, PhCH, PhCH), 4.73 (d, 1H, J = 10.9 Hz, PhCH), 4.63 (d, 1H, J
= 12.2 Hz, PhCH), 4.56−4.51 (m, 3H, H-1′, PhCH, PhCH), 4.22−
4.18 (m, 1H, H-6), 3.92−3.86 (m, 2H, H-4′, H-6), 3.74 (dd, 1H, J =
10.7, 2.0 Hz, H-6′), 3.70−3.64 (m, 3H, H-4, H-5, H-6′), 3.59 (app t,
1H, J = 9.2 Hz, H-3′), 3.53−3.48 (m, 2H, H-2′, H-5′), 3.35 (s, 3H,
OCH3), 2.90 (d, 1H, J = 5.6 Hz, 4-OH), 1.19 (s, 9H, (CH3)3CCO),
1.18 (s, 9H, (CH3)3CCO). 13C NMR (100 MHz, CDCl3): δ (ppm)
179.4, 177.9, 138.7, 138.5, 138.2, 138.2, 138.52, 128.50, 128.49,
128.49, 128.48, 128.2, 128.1, 128.0, 127.9, 127.8, 127.76, 127.72,
104.0, 95.8, 84.8, 82.1, 77.9, 75.8, 75.1, 75.0, 74.9, 73.6, 73.2, 70.8,
70.7, 70.6, 69.0, 68.9, 55.5, 39.0, 38.9, 27.3, 27.1. HRMS (ESI, m/z):
calcd for [C51H68NO13] (M + NH4)+ 902.4685, found 902.4694.
Methyl 2,3-Bis-O-benzoyl-6-O-(2′,3′,4′,6′-tetra-O-benzyl-β-D-glu-
copyranosyl)-α-D-glucopyranoside (6e). 2,3-Bis-O-benzoyl-α-D-glu-
copyranoside14 (0.053 g, 0.132 mmol, 1.00 equiv) and phenylboronic
acid (0.016 g, 0.132 mmol, 1.00 equiv) were placed in a round-bottom
flask equipped with stir bar. Toluene (1.00 mL) was added to the flask,
and the solution was placed in an oil bath set at 110 °C and stirred
overnight. The solution was then cooled to room temperature, and
solvent was removed under reduced pressure. Residual water was
removed from the resulting material via azeotroping with toluene three
times, followed by drying under high vacuum to yield a white solid.
The resulting material was then dissolved in anhydrous dichloro-
methane (1.00 mL) and transferred via syringe to an oven-dried
round-bottom flask charged with a stir bar and 4 Å molecular sieves.
2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl chloride (0.081 g, 0.145
mmol, 1.10 equiv) and silver(I) oxide (0.034 g, 0.145 mmol, 1.10
equiv) were added to the solution followed by triethylamine (0.110
mL, 0.792 mmol, 6.00 equiv), and the reaction was stirred vigorously
(800 rpm or higher) at room temperature for 48 h. The reaction was
quenched with methanol and filtered through a pad of tightly packed
Celite followed by removal of the solvent under reduced pressure. The
crude material was purified by flash column chromatography on silica
gel (gradient elution, ethyl acetate in hexanes) to give a white solid.
This material was purified further by flash column chromatography on
silica gel (acetone/toluene 1:9) to yield the pure compound as a white
amorphous solid (0.050 g, 41%). TLC: Rf = 0.34 (ethyl acetate/
hexanes 1:1). [α]20D = 33.1 (c 0.98 in CHCl3) FTIR (powder, cm−1):
3446 (br), 3031 (w), 2908 (w), 1722 (s), 1452 (m), 1275 (s), 1092
Methyl 3-O-(2′,3′,4′,6′-Tetra-O-benzyl-β-D-glucopyranosyl)-4-O-
benzoyl-α-L-rhamnopyranoside (6b). Prepared from methyl 2,3-O-
(phenylboronate)-α-L-rhamnopyranoside (0.053 g, 0.200 mmol)
according to general procedure D. The title compound was purified
by flash column chromatography on silica gel (gradient elution, ethyl
acetate in hexanes) to yield a white amorphous solid (0.115 g, 71%).
TLC: Rf = 0.65 (ethyl acetate/hexanes 2:3). [α]20 = 1.6 (c 1.13 in
D
CHCl3). FTIR (powder, cm−1): 3532 (br), 2918 (W), 2837 (s), 1744
1
(s), 1514 (m), 1367 (m), 1216 (s), 1033 (s), 907 (m), 800 (m). H
NMR (400 MHz, CDCl3): δ (ppm) 7.94−7.91 (m, 2H, ArH), 7.45−
7.41 (m, 1H, ArH), 7.35−7.32 (m, 4H, ArH), 7.31−7.25 (m, 6H,
ArH), 7.25−7.20 (m, 3H, ArH), 7.17−7.10 (m, 5H, ArH), 7.08−7.03
(m, 2H, ArH), 6.89−6.86 (m, 2H, ArH), 5.48 (app t, 1H, J = 9.4 Hz,
H-4), 4.78−4.71 (m, 3H, H-1, PhCH, PhCH), 4.64 (d, 1H, J = 11.0
Hz, PhCH), 4.55−4.47 (m, 5H, H-1′, PhCH, PhCH, PhCH, PhCH),
4.35 (d, 1H, J = 11.6 Hz, PhCH), 4.20−4.16 (m, 2H, H-2, H-3), 3.96−
3.91 (m, 1H, H-5), 3.68 (dd, 1H, J = 10.3, 1.2 Hz, H-6′), 3.56−3.46
(m, 4H, H-3′, H-4′, H-5′, H-6′), 3.44−3.39 (m, 4H, H-2′, OCH3),
3.22 (d, 1H, J = 2.7 Hz, 2-OH), 1.26 (d, 3H, J = 6.3 Hz, CH3). 13C
NMR (100 MHz, CDCl3): δ (ppm) 165.8, 138.5, 138.2, 138.1, 138.1,
133.1, 129.9, 129.8, 128.6, 128.52, 128.48, 128.37, 128.2, 128.1, 128.0,
127.95, 127.87, 127.82, 127.7, 127.6, 127.3, 103.5, 100.7, 84.7, 81.8,
79.5, 77.8, 75.7, 75.1, 74.7, 74.5, 73.7, 72.8, 69.8, 69.3, 66.3, 55.1, 17.7.
HRMS (ESI, m/z): calcd for [C48H56NO11] (M + NH4)+ 822.3848,
found 822.3848.
Methyl 2-O-Benzoyl-3-O-(2′,3′,4′,6′-tetra-O-benzyl-β-D-glucopyr-
anosyl)-α-L-fucopyranoside (6c). Prepared from methyl 3,4-O-
(phenylboronate)-α-L-fucopyranoside (0.053 g, 0.200 mmol) accord-
ing to general procedure D. The title compound was purified by flash
column chromatography on silica gel (gradient elution, ethyl acetate in
hexanes) to yield a white amorphous solid (0.142 g, 88%). TLC: Rf =
0.78 (ethyl acetate/hexanes 2:3). [α]20 = −24.4 (c 1.05 in CHCl3).
D
FTIR (powder, cm−1): 3470 (br), 3030 (w), 2906 (w), 1717 (m),
1496 (w), 1452 (m), 1274 (m), 1052 (s), 1027 (s), 999 (s), 960 (m),
1
1
(s), 1063 (s), 1026 (s), 914 (w), 735 (m), 693 (s). H NMR (400
912 (m), 735 (s), 693 (s). H NMR (400 MHz, CDCl3): δ (ppm)
MHz, CDCl3): δ (ppm) 7.96−7.90 (m, 4H, o-Bz), 7.48−7.47 (m, 2H,
p-Bz), 7.34−7.17 (m, 22H, ArH), 7.12−7.10 (m, 2H, ArH), 5.72 (dd,
1H, J = 10.1, 9.1 Hz, H-3), 5.19 (dd, 1H, J = 10.1, 3.7 Hz, H-2), 5.10
(d, 1H, J = 3.7 Hz, H-1), 4.97 (d, 1H, J = 11.0 Hz, PhCH), 4.89 (d,
1H, J = 11.0 Hz, PhCH), 4.78−4.71 (m, 3H, PhCH, PhCH, PhCH),
4.55−4.44 (m, 2H, PhCH, PhCH), 4.50 (d, 1H, J = 7.7 Hz, H-1′),
4.18 (dd, 1H, J = 10.5, 2.0 Hz, H-6), 3.98−3.90 (m, 3H, H-5, H-6),
3.88 (app t, 1H, J = 9.1 Hz, H-4), 3.69 (dd, 1H, J = 10.7, 1.9 Hz, H-
6′), 3.65−3.44 (m, 5H, H-2′, H-3′, H-4′, H-5′, H-6′), 3.35 (s, 3H,
OCH3). 13C NMR (100 MHz, CDCl3): δ (ppm) 167.3, 166.1, 138.7,
138.5, 138.2, 138.1, 133.4, 133.4, 129.99, 129.97, 129.5, 129.4, 128.53,
128.50, 128.50, 128.50, 128.50, 128.48, 128.1, 128.05, 127.96, 127.96,
127.89, 127.8, 127.76, 127.74, 103.9, 97.2, 84.8, 82.1, 77.9, 75.8,75.1,
75.0, 75.0, 74.2, 73.6, 71.7, 70.8, 70.3, 68.9, 68.8, 55.5. HRMS (ESI, m/
z): calcd for [C55H60NO13] (M + NH4)+ 942.4059, found 942.4053.
Acyl migration byproducts 6e′, 6e″, and 6f were also isolated from the
reaction. 1H and 13C NMR characterization data are provided. Methyl
3,4-Bis-O-benzoyl-6-O-(2′,3′,4′,6′-tetra-O-benzyl-β-D-glucopyranosyl)-
8.14−8.11 (m, 2H, o-Bz), 7.53−7.48 (m, 1H, p-Bz), 7.37−7.28 (m,
20H, ArH), 7.19−7.17 (m, 2H, ArH), 5.46 (dd, 1H, J = 10.3, 3.8 Hz,
H-2), 5.09 (dm 1H, J = 3.8 Hz, H-1), 4.92 (d, 1H, J = 11.0 Hz,
PhCH), 4.87−4.84 (m, 3H, PhCH, PhCH, PhCH), 4.80 (d, 1H, J =
10.7 Hz, PhCH), 4.59−4.47 (m, 4H, H-1′, PhCH, PhCH, PhCH),
4.46 (dd, 1H, J = 10.2, 3.2 Hz, H-3), 4.02−3.95 (m, 2H, H-4, H-5),
3.67−3.59 (m, 4H, H-3′, H-4′, H-6′, H-6′), 3.44 (dd, 1H, J = 8.8, 7.9
Hz, H-2′), 3.42−3.37 (m, 4H, H-5′, OCH3), 1.34 (d, 3H, J = 6.6 Hz,
CH3). 13C NMR (100 MHz, CDCl3): δ (ppm) 166.3, 138.5, 138.2,
138.1, 137.9, 133.0, 130.3, 130.0, 128.6, 128.5, 128.5, 138.46, 128.4,
128.2, 128.1, 128.0, 127.9, 127.8, 127.76, 127.73, 127.67, 99.8, 97.7,
85.1, 81.8, 78.0, 75.6, 75.5, 75.4, 75.1, 74.7, 73.7, 69.7, 69.3, 68.7, 65.3,
55.4, 16.3. HRMS (ESI, m/z): calcd for [C48H56NO11] (M + NH4)+
822.3848, found 822.3856.
Methyl 2,3-Bis-O-trimethylacetyl-6-O-(2′,3′,4′,6′-tetra-O-benzyl-
β-D-glucopyranosyl)-α-D-glucopyranoside (6d). Prepared from meth-
yl 4,6-O-(phenylboronate)-α-D-galactopyranoside (0.056 g, 0.200
mmol) according to general procedure D with the following
amendment: instead of benzoyl chloride, trimethylacetyl chloride
(98.0 μL, 0.800 mmol, 4.00 equiv) was used as the acylating agent and
the acylation step was run for 16 h at 50 °C. The title compound was
purified by flash column chromatography on silica gel (gradient
elution, ethyl acetate in hexanes) to yield a white amorphous solid
1
α-D-glucopyranoside (6e′). H NMR (400 MHz, CDCl3): δ (ppm)
7.96−7.90 (m, 4H, o-Bz), 7.51−7.47 (m, 2H, p-Bz), 7.41−7.23 (m,
22H, ArH), 7.16−7.13 (m, 2H, ArH), 5.70 (app t, 1H, J = 9.8 Hz, H-
3), 5.38 (app t, 1H, J = 9.8 Hz, H-4), 5.06 (d, 1H, J = 10.9 Hz, PhCH),
4.92 (d, 1H, J = 11.0 Hz, PhCH), 4.89 (d, 1H, J = 3.7 Hz, H-1), 4.81
(d, 1H, J = 10.7 Hz, PhCH), 4.77 (d, 1H, J = 10.7 Hz, PhCH), 4.69 (d,
1H, J = 11.0 Hz, PhCH), 4.54−4.50 (m, 2H, PhCH, PhCH), 4.47−
4.42 (m, 2H, H-1′, PhCH), 4.29−4.24 (m, 1H, H-5), 4.09 (dd, 1H, J =
(0.112 g, 63%). TLC: Rf = 0.62 (ethyl acetate/hexanes 2:3). [α]20
=
D
26.5 (c 1.30 in CHCl3). FTIR (powder, cm−1): 3458 (br), 2969 (w),
2933 (w), 2915 (w), 2876 (w), 1732 (s), 1454 (m), 1281 (m), 1146
J
J. Org. Chem. XXXX, XXX, XXX−XXX